Advertisement

Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders

      Background

      Late-onset Alzheimer's disease (AD) is a multifactorial and heterogeneous disorder with major risk factors including advanced age, presence of an apolipoprotein E ε4 (APOE4) allele, and family history of AD. Other risk factors may be obesity and diabetes and related disorders, which are highly prevalent.

      Methods

      We reviewed longitudinal epidemiological studies of body mass, diabetes, metabolic syndrome, and glucose and insulin levels on risk for AD. We conducted meta-analyses of the results from these studies.

      Results

      For obesity assessed by body mass index, the pooled effect size for AD was 1.59 (95% confidence interval [CI] 1.02–2.5; z = 2.0; p = .042), and for diabetes, the pooled effect size for AD was 1.54 (95% CI 1.33–1.79; z = 5.7; p < .001). Egger's test did not find significant evidence for publication bias in the meta-analysis for obesity (t = −1.4, p = .21) or for diabetes (t = −.86, p = .42). Since these disorders are highly comorbid, we conducted a meta-analysis combining all studies of obesity, diabetes, and abnormal glucose or insulin levels, which yielded a highly significant pooled effect size for AD of 1.63 (95% CI 1.39–1.92; z = 5.9; p < .001).

      Conclusions

      Obesity and diabetes significantly and independently increase risk for AD. Though the level of risk is less than that with the APOE4 allele, the high prevalence of these disorders may result in substantial increases in future incidence of AD. Physiological changes common to obesity and diabetes plausibly promote AD.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Tanzi R.E.
        • Bertram L.
        Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective.
        Cell. 2005; 120: 545-555
        • DerSimonian R.
        • Laird N.
        Meta-analysis in clinical trials.
        Control Clin Trials. 1986; 7: 177-188
        • Woolf B.
        On estimating the relation between blood group and disease.
        Ann Hum Genet. 1955; 19: 251-253
        • Egger M.
        • Davey Smith G.
        • Schneider M.
        • Minder C.
        Bias in meta-analysis detected by a simple, graphical test.
        BMJ. 1997; 315: 629-634
        • Stata Corporation
        Stata User's Guide: Release 9.
        Stata Corporation, College Station, TX2005
        • Kivipelto M.
        • Ngandu T.
        • Fratiglioni L.
        • Viitanen M.
        • Kareholt I.
        • Winblad B.
        • et al.
        Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.
        Arch Neurol. 2005; 62: 1556-1560
        • Whitmer R.A.
        • Gunderson E.P.
        • Quesenberry Jr, C.P.
        • Zhou J.
        • Yaffe K.
        Body mass index in midlife and risk of Alzheimer disease and vascular dementia.
        Curr Alzheimer Res. 2007; 4: 103-109
        • Beydoun M.A.
        • Lhotsky A.
        • Wang Y.
        • Dal Forno G.
        • An Y.
        • Metter E.J.
        • et al.
        Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease.
        Am J Epidemiol. 2008; 168: 1179-1189
        • Hayden K.M.
        • Zandi P.P.
        • Lyketsos C.G.
        • Khachaturian A.S.
        • Bastian L.A.
        • Charoonruk G.
        • et al.
        Vascular risk factors for incident Alzheimer disease and vascular dementia: The Cache County study.
        Alzheimer Dis Assoc Disord. 2006; 20: 93-100
        • Luchsinger J.A.
        • Patel B.
        • Tang M.X.
        • Schupf N.
        • Mayeux R.
        Measures of adiposity and dementia risk in elderly persons.
        Arch Neurol. 2007; 64: 392-398
        • Xu W.
        • Qiu C.
        • Winblad B.
        • Fratiglioni L.
        The effect of borderline diabetes on the risk of dementia and Alzheimer's disease.
        Diabetes. 2007; 56: 211-216
        • Gustafson D.
        • Rothenberg E.
        • Blennow K.
        • Steen B.
        • Skoog I.
        An 18-year follow-up of overweight and risk of Alzheimer disease.
        Arch Intern Med. 2003; 163: 1524-1528
        • Stewart R.
        • Masaki K.
        • Xue Q.L.
        • Peila R.
        • Petrovitch H.
        • White L.R.
        • et al.
        A 32-year prospective study of change in body weight and incident dementia: The Honolulu-Asia Aging Study.
        Arch Neurol. 2005; 62: 55-60
        • Barrett-Connor E.
        • Edelstein S.L.
        • Corey-Bloom J.
        • Wiederholt W.C.
        Weight loss precedes dementia in community-dwelling older adults.
        J Am Geriatr Soc. 1996; 44: 1147-1152
        • Buchman A.S.
        • Wilson R.S.
        • Bienias J.L.
        • Shah R.C.
        • Evans D.A.
        • Bennett D.A.
        Change in body mass index and risk of incident Alzheimer disease.
        Neurology. 2005; 65: 892-897
        • Johnson D.K.
        • Wilkins C.H.
        • Morris J.C.
        Accelerated weight loss may precede diagnosis in Alzheimer disease.
        Arch Neurol. 2006; 63: 1312-1317
        • Yoshitake T.
        • Kiyohara Y.
        • Kato I.
        • Ohmura T.
        • Iwamoto H.
        • Nakayama K.
        • et al.
        Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study.
        Neurology. 1995; 45: 1161-1168
        • Leibson C.L.
        • Rocca W.A.
        • Hanson V.A.
        • Cha R.
        • Kokmen E.
        • O'Brien P.C.
        • et al.
        Risk of dementia among persons with diabetes mellitus: A population-based cohort study.
        Am J Epidemiol. 1997; 145: 301-308
        • Ott A.
        • Stolk R.P.
        • van Harskamp F.
        • Pols H.A.
        • Hofman A.
        • Breteler M.M.
        Diabetes mellitus and the risk of dementia: The Rotterdam Study.
        Neurology. 1999; 53: 1937-1942
        • Luchsinger J.A.
        • Tang M.X.
        • Stern Y.
        • Shea S.
        • Mayeux R.
        Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.
        Am J Epidemiol. 2001; 154: 635-641
        • MacKnight C.
        • Rockwood K.
        • Awalt E.
        • McDowell I.
        Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.
        Dement Geriatr Cogn Disord. 2002; 14: 77-83
        • Peila R.
        • Rodriguez B.L.
        • Launer L.J.
        • Honolulu-Asia Aging Study
        Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study.
        Diabetes. 2002; 51: 1256-1262
        • Arvanitakis Z.
        • Wilson R.S.
        • Bienias J.L.
        • Evans D.A.
        • Bennett D.A.
        Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.
        Arch Neurol. 2004; 61: 661-666
        • Luchsinger J.A.
        • Tang M.X.
        • Shea S.
        • Mayeux R.
        Hyperinsulinemia and risk of Alzheimer disease.
        Neurology. 2004; 63: 1187-1192
        • Xu W.L.
        • Qiu C.X.
        • Wahlin A.
        • Winblad B.
        • Fratiglioni L.
        Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study.
        Neurology. 2004; 63: 1181-1186
        • Akomolafe A.
        • Beiser A.
        • Meigs J.B.
        • Au R.
        • Green R.C.
        • Farrer L.A.
        • et al.
        Diabetes mellitus and risk of developing Alzheimer disease: Results from the Framingham Study.
        Arch Neurol. 2006; 63: 1551-1555
        • Curb J.D.
        • Rodriguez B.L.
        • Abbott R.D.
        • Petrovitch H.
        • Ross G.W.
        • Masaki K.H.
        • et al.
        Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance.
        Neurology. 1999; 52: 971-975
        • Kalmijn S.
        • Foley D.
        • White L.
        • Burchfiel C.M.
        • Curb J.D.
        • Petrovitch H.
        • et al.
        Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men.
        Arterioscler Thromb Vasc Biol. 2000; 20: 2255-2260
        • Corder E.H.
        • Saunders A.M.
        • Strittmatter W.J.
        • Schmechel D.E.
        • Gaskell P.C.
        • Small G.W.
        • et al.
        Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
        Science. 1993; 261: 921-923
        • Fewlass D.C.
        • Noboa K.
        • Pi-Sunyer F.X.
        • Johnston J.M.
        • Yan S.D.
        • Tezapsidis N.
        Obesity-related leptin regulates Alzheimer's Abeta.
        FASEB J. 2004; 18: 1870-1878
        • Tschape J.A.
        • Hammerschmied C.
        • Muhlig-Versen M.
        • Athenstaedt K.
        • Daum G.
        • Kretzschmar D.
        The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing.
        EMBO J. 2002; 21: 6367-6376
        • Culmsee C.
        • Monnig J.
        • Kemp B.E.
        • Mattson M.P.
        AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation.
        J Mol Neurosci. 2001; 17: 45-58
        • Mattson M.P.
        • Barger S.W.
        • Furukawa K.
        • Bruce A.J.
        • Wyss-Coray T.
        • Mark R.J.
        • et al.
        Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease.
        Brain Res Brain Res Rev. 1997; 23: 47-61
        • Spranger J.
        • Verma S.
        • Gohring I.
        • Bobbert T.
        • Seifert J.
        • Sindler A.L.
        • et al.
        Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells.
        Diabetes. 2006; 55: 141-147
        • Rosen E.D.
        • Spiegelman B.M.
        Adipocytes as regulators of energy balance and glucose homeostasis.
        Nature. 2006; 444: 847-853
        • Profenno L.A.
        • Faraone S.V.
        Diabetes and overweight associate with non-APOE4 genotype in an Alzheimer's disease population.
        Am J Med Genet B Neuropsychiatr Genet. 2008; 147B: 822-829
        • Han B.H.
        • Zhou M.L.
        • Abousaleh F.
        • Brendza R.P.
        • Dietrich H.H.
        • Koenigsknecht-Talboo J.
        • et al.
        Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: Contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
        J Neurol Sci. 2008; 28: 13542-13550
        • Utter S.
        • Tamboli I.Y.
        • Walter J.
        • Upadhaya A.R.
        • Birkenmeier G.
        • Pietrzik C.U.
        • et al.
        Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
        J Neuropathol Exp Neurol. 2008; 67: 842-856
        • Harvey J.
        • Solovyova N.
        • Irving A.
        Leptin and its role in hippocampal synaptic plasticity.
        Prog Lipid Res. 2006; 45: 369-378
        • McEwen B.S.
        Corticosteroids and hippocampal plasticity.
        Ann N Y Acad Sci. 1994; 746: 134-142
        • Xu X.
        • Zhang Z.
        Effects of estradiol benzoate on learning-memory behavior and synaptic structure in ovariectomized mice.
        Life Sci. 2006; 79: 1553-1560
        • Maher F.O.
        • Clarke R.M.
        • Kelly A.
        • Nally R.E.
        • Lynch M.A.
        Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation.
        J Neurochem. 2006; 96: 1560-1571
        • Sathiavageeswaran M.
        • Burman P.
        • Lawrence D.
        • Harris A.G.
        • Falleti M.G.
        • Maruff P.
        • et al.
        Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: A placebo-controlled 12-month study.
        Eur J Endocrinol. 2007; 156: 439-447
        • Park C.R.
        • Seeley R.J.
        • Craft S.
        • Woods S.C.
        Intracerebroventricular insulin enhances memory in a passive-avoidance task.
        Physiol Behav. 2000; 68: 509-514
        • Alzoubi K.H.
        • Gerges N.Z.
        • Alkadhi K.A.
        Levothyroxine restores hypothyroidism-induced impairment of LTP of hippocampal CA1: Electrophysiological and molecular studies.
        Exp Neurol. 2005; 195: 330-341
        • Bertram L.
        • McQueen M.B.
        • Mullin K.
        • Blacker D.
        • Tanzi R.E.
        Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database.
        Nat Genet. 2007; 39: 17-23